These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 21193326)
21. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571 [TBL] [Abstract][Full Text] [Related]
22. Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation. Trento A; Hardesty RL; Griffith BP; Zerbe T; Kormos RL; Bahnson HT J Thorac Cardiovasc Surg; 1988 Jan; 95(1):37-41. PubMed ID: 2447445 [TBL] [Abstract][Full Text] [Related]
23. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells. Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183 [TBL] [Abstract][Full Text] [Related]
24. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Bishop DK; Shelby J; Eichwald EJ Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070 [TBL] [Abstract][Full Text] [Related]
34. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy? Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082 [TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection. Pelletier R; Ohye R; Kincade P; Ferguson R; Orosz C Transplant Proc; 1993 Feb; 25(1 Pt 1):839-41. PubMed ID: 7679845 [No Abstract] [Full Text] [Related]
36. The changing pattern of humoral rejection in cardiac transplant recipients. Almuti K; Haythe J; Dwyer E; Itescu S; Burke E; Green P; Marboe C; Mancini D Transplantation; 2007 Aug; 84(4):498-503. PubMed ID: 17713434 [TBL] [Abstract][Full Text] [Related]
37. Vascular cell adhesion molecule-1 is induced on endothelium during acute rejection in human cardiac allografts. Carlos T; Gordon D; Fishbein D; Himes VE; Coday A; Ross R; Allen MD J Heart Lung Transplant; 1992; 11(6):1103-8; discussion 1109. PubMed ID: 1280999 [TBL] [Abstract][Full Text] [Related]
38. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation. Harrison PC; Mainolfi E; Madwed JB J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853 [TBL] [Abstract][Full Text] [Related]
39. Immunostaining of cardiac biopsy specimens in the diagnosis of acute vascular (humoral) rejection: a control study. Loy TS; Bulatao IS; Darkow GV; Demmy TL; Reddy HK; Curtis J; Bickel JT J Heart Lung Transplant; 1993; 12(5):736-40. PubMed ID: 7694654 [TBL] [Abstract][Full Text] [Related]